Seasonal Allergic Rhinitis Clinical Trials

9 recruiting

Seasonal Allergic Rhinitis Trials at a Glance

8 actively recruiting trials for seasonal allergic rhinitis are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Beijing, Beijing, and Bruges. Lead sponsors running seasonal allergic rhinitis studies include Beijing Tongren Hospital, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, and Alixer Nexgen Therapeutics Limited.

Browse seasonal allergic rhinitis trials by phase

Treatments under study

About Seasonal Allergic Rhinitis Clinical Trials

Looking for clinical trials for Seasonal Allergic Rhinitis? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Seasonal Allergic Rhinitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Seasonal Allergic Rhinitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

Seasonal Allergic RhinitisPerennial Allergic RhinitisLocal Allergic Rhinitis
Universitaire Ziekenhuizen KU Leuven200 enrolled2 locationsNCT04544774
Recruiting
Phase 2

Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.300 enrolled30 locationsNCT07398859
Recruiting
Phase 2

A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure

Seasonal Allergic Rhinitis (SAR)
Alixer Nexgen Therapeutics Limited164 enrolled1 locationNCT07219849
Recruiting
Phase 2

Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Beijing Tongren Hospital120 enrolled1 locationNCT06300203
Recruiting
Phase 2

A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Guangdong Hengrui Pharmaceutical Co., Ltd100 enrolled1 locationNCT07091357
Recruiting
Not Applicable

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Allergic AsthmaAsthma AcuteThunderstorm Asthma+3 more
University of Melbourne530 enrolled1 locationNCT07055542
Recruiting
Not Applicable

Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Guang'anmen Hospital of China Academy of Chinese Medical Sciences120 enrolled1 locationNCT04815668
Recruiting
Phase 2Phase 3

Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Shanghai Mabgeek Biotech.Co.Ltd160 enrolled1 locationNCT06846385